WPP
ABBV icon

Whalerock Point Partners’s AbbVie ABBV Stock Holding History

Whalerock Point Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49M Hold
11,453
– – 0.48% 42
2025
Q4 		$2.62M Sell
11,453
-486
-4% -$111K 0.5% 42
2025
Q3 		$2.76M Hold
11,939
– – 0.56% 39
2025
Q2 		$2.22M Buy
11,939
+250
+2% +$46.5K 0.48% 44
2025
Q1 		$2.45M Buy
11,689
+225
+2% +$43.7K 0.58% 41
2024
Q4 		$2.04M Hold
11,464
– – 0.47% 43
2024
Q3 		$2.26M Buy
11,464
+200
+2% +$37.3K 0.54% 43
2024
Q2 		$1.93M Buy
11,264
+200
+2% +$33.1K 0.52% 41
2024
Q1 		$2.01M Buy
11,064
+150
+1% +$25.9K 0.55% 41
2023
Q4 		$1.69M Hold
10,914
– – 0.52% 45
2023
Q3 		$1.63M Buy
10,914
+480
+5% +$70.5K 0.56% 44
2023
Q2 		$1.41M Sell
10,434
-82
-0.8% -$12K 0.48% 48
2023
Q1 		$1.68M Buy
10,516
+255
+2% +$39K 0.62% 42
2022
Q4 		$1.66M Buy
10,261
+36
+0.4% +$5.52K 0.67% 42
2022
Q3 		$1.37M Buy
10,225
+1,325
+15% +$190K 0.6% 44
2022
Q2 		$1.36M Buy
8,900
+257
+3% +$39.3K 0.58% 46
2022
Q1 		$1.4M Hold
8,643
– – 0.5% 47
2021
Q4 		$1.17M Buy
8,643
+400
+5% +$47.3K 0.4% 50
2021
Q3 		$889K Buy
8,243
+1,192
+17% +$136K 0.34% 61
2021
Q2 		$794K Buy
7,051
+50
+0.7% +$5.63K 0.31% 63
2021
Q1 		$758K Buy
7,001
+900
+15% +$96.3K 0.33% 62
2020
Q4 		$654K Buy
6,101
+5,642
+1,229% +$542K 0.31% 62
2020
Q3 		$459K Sell
459
-4,215
-90% -$397K 0.25% 73
2020
Q2 		$459K Hold
4,674
– – 0.27% 71
2020
Q1 		$356K Buy
4,674
+600
+15% +$51.1K 0.25% 78
2019
Q4 		$361K Sell
4,074
-100
-2% -$8.3K 0.19% 99
2019
Q3 		$316K Sell
4,174
-125
-3% -$8.57K 0.17% 110
2019
Q2 		$313K Hold
4,299
– – 0.18% 107
2019
Q1 		$346K Buy
4,299
+374
+10% +$30.6K 0.23% 92
2018
Q4 		$362K Hold
3,925
– – 0.34% 66
2018
Q3 		$371K Hold
3,925
– – 0.27% 79
2018
Q2 		$364K Sell
3,925
-374
-9% -$36.5K 0.29% 75
2018
Q1 		$407K Sell
4,299
-75
-2% -$8.24K 0.13% 124
2017
Q4 		$423K Hold
4,374
– – 0.13% 116
2017
Q3 		$388K Sell
4,374
-75
-2% -$5.71K 0.14% 102
2017
Q2 		$323K Sell
4,449
-75
-2% -$5.04K 0.12% 112
2017
Q1 		$294K Sell
4,524
-100
-2% -$6.29K 0.11% 111
2016
Q4 		$289K Buy
4,624
+449
+11% +$27.4K 0.11% 111
2016
Q3 		$263K Buy
+4,175
New +$270K 0.11% 119
2016
Q1 		$259K Sell
4,550
-500
-10% -$27.9K 0.11% 121
2015
Q4 		$299K Sell
5,050
-1,570
-24% -$90.4K 0.13% 113
2015
Q3 		$360K Buy
6,620
+670
+11% +$43.6K 0.16% 107
2015
Q2 		$399K Hold
5,950
– – 0.16% 96
2015
Q1 		$348K Sell
5,950
-125
-2% -$7.55K 0.14% 111
2014
Q4 		$397K Buy
6,075
+225
+4% +$14.2K 0.17% 93
2014
Q3 		$337K Buy
5,850
+150
+3% +$8.33K 0.15% 105
2014
Q2 		$321K Buy
5,700
+750
+15% +$39.3K 0.15% 100
2014
Q1 		$254K Hold
4,950
– – 0.13% 102
2013
Q4 		$261K Buy
+4,950
New +$243K 0.14% 98

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Whalerock Point Partners's ABBV Position: Q1 2026 in Review

Whalerock Point Partners held its AbbVie (ABBV) position steady in Q1 2026 at 11,453 shares worth $2.49M. The position accounts for 0.48% of the portfolio, ranked #42.

Whalerock Point Partners first reported a position in ABBV in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.76M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Whalerock Point Partners held 11,453 shares of AbbVie worth $2.49M as of Q1 2026.
  • Whalerock Point Partners left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.48% of Whalerock Point Partners's portfolio in Q1 2026, its #42 holding.
  • Whalerock Point Partners first reported a position in AbbVie in Q4 2013 and has held it in 49 quarters since.
  • Whalerock Point Partners's AbbVie position peaked at $2.76M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.